The most common side effects may include nausea, diarrhea, vomiting, constipation, stomach pain, headache, fatigue, dizziness, bloating, gas, and heartburn.
Even intravenous administration of GLP-1 at a physiological postprandial dose of 0.3 pmol/kg/min significantly slowed the rate of gastric emptying in healthy subjects, bringing them into a state of gastroparesis (Little et al., 2006)
At higher doses (1.52mg), the incidence of gastrointestinal symptoms increases, and the theoretical risk of phosphate dysregulation becomes more relevant
Names, labels, devices, and payer rules are levers that shape outcomes
Different forms serve different purposes: Acetyl-L-carnitine supports brain health, while L-Carnitine-L-Tartrate aids muscle recovery
This systematic review aims to comprehensively evaluate the role of GLP-1 in headache and pain disorders